MLAB Stock Overview
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Mesa Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$132.08 |
| 52 Week High | US$141.17 |
| 52 Week Low | US$83.68 |
| Beta | 0.86 |
| 1 Month Change | 21.07% |
| 3 Month Change | 4.70% |
| 1 Year Change | 25.69% |
| 3 Year Change | -59.84% |
| 5 Year Change | -46.60% |
| Change since IPO | 4,212.82% |
Recent News & Updates
Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle
Dec 19Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding
Nov 20
Recent updates
Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle
Dec 19Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding
Nov 20We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt
Oct 17A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb
Jul 29Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?
May 03Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?
Mar 15Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 08Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?
Dec 05Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?
Sep 28Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Aug 09We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt
Jun 28Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking
May 31A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Apr 12Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Mar 13Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Dec 20Mesa Laboratories declares $0.16 dividend
Oct 03Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced
Sep 09Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?
Sep 06Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Aug 08Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M
Aug 04Mesa Laboratories declares $0.16 dividend
Jul 07Shareholder Returns
| MLAB | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 3.5% | -2.1% | -2.4% |
| 1Y | 25.7% | -5.5% | 23.3% |
Return vs Industry: MLAB exceeded the US Life Sciences industry which returned -5.5% over the past year.
Return vs Market: MLAB exceeded the US Market which returned 23.3% over the past year.
Price Volatility
| MLAB volatility | |
|---|---|
| MLAB Average Weekly Movement | 8.0% |
| Life Sciences Industry Average Movement | 9.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MLAB has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MLAB's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 736 | Gary Owens | www.mesalabs.com |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries.
Mesa Laboratories, Inc. Fundamentals Summary
| MLAB fundamental statistics | |
|---|---|
| Market cap | US$717.38m |
| Earnings (TTM) | -US$245.65m |
| Revenue (TTM) | US$228.38m |
3.1x
P/S Ratio-2.9x
P/E RatioIs MLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLAB income statement (TTM) | |
|---|---|
| Revenue | US$228.38m |
| Cost of Revenue | US$83.26m |
| Gross Profit | US$145.12m |
| Other Expenses | US$390.77m |
| Earnings | -US$245.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -45.23 |
| Gross Margin | 63.54% |
| Net Profit Margin | -107.56% |
| Debt/Equity Ratio | 127.0% |
How did MLAB perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield-1%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mesa Laboratories, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vijay Kumar | Evercore ISI |
| Paul Knight | Janney Montgomery Scott LLC |
| Tycho Peterson | Jefferies LLC |